---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-24-006349"
form_type: "8-K"
ticker: "NXL"
cik: "0001527352"
company_name: "Nexalin Technology, Inc."
filed_at: "2024-09-19T23:59:59+00:00"
generated_at: "2026-05-31T03:36:34.161717+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Nexalin appoints Carolyn Shelton as SVP Quality, Regulatory & Clinical Affairs

## Summary
- Carolyn Shelton appointed SVP Quality, Regulatory and Clinical Affairs effective Sept 16, 2024.
- Base salary of $300,000; annual discretionary bonus of $40,000 based on milestones.
- Stock options valued at $60,000 under 2023 Equity Incentive Plan, vesting equally over 3 years from Sept 16, 2025.
- Prior roles include VP Regulatory/Quality at Openwater Health, Advanced Sterilization Products, and Medtronic.
- Relocation expenses up to $5,000; five weeks paid time off per year.

## SEC filing metadata
- accession: 0001829126-24-006349
- form_type: 8-K
- ticker: NXL
- cik: 0001527352
- company_name: Nexalin Technology, Inc.
- filed_at: 2024-09-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1527352/000182912624006349/0001829126-24-006349-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1527352/000182912624006349/nexalintec_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-24-006349
- JSON: https://secwatch.observer/filing/0001829126-24-006349.json
- Plain text: https://secwatch.observer/filing/0001829126-24-006349.txt

## Key facts
- Executive change
  Carolyn Shelton was appointed as Senior Vice President Quality, Regulatory and Clinical Affairs at Nexalin Technology, Inc..
  - Action: appointed
  - Role: Senior Vice President Quality, Regulatory and Clinical Affairs
  source text: On September 16, 2024, Nexalin Technology, Inc. (“Nexalin”) appointed Carolyn Shelton as Senior Vice President Quality, Regulatory and Clinical Affairs, effective as of September 16, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1527352/000182912624006349/0001829126-24-006349-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.